Market Place
Sourcing Support
All News #Library
Quality
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
FDA hit Catalent`s Maryland Manufacturing Sites with Form 483
19 Dec 2025 //
FIERCE PHARMA
Novo Gets Warning Letter At Site Formerly Owned By Catalent
17 Dec 2025 //
FIERCE PHARMA
Novo Plant Issues May Mean Delays For Regeneron, Scholar Rock
13 Oct 2025 //
FIERCE PHARMA
Catalent`s Newly Acquired Novo Plant Under FDA Scrutiny
22 Aug 2025 //
FIERCE PHARMA
Catalent’s Indiana site closes out three Form 483s in past two years
08 Feb 2024 //
ENDPTS
US FDA finds control lapses at Catalent plant being sold to Novo
06 Feb 2024 //
REUTERS
FDA inspection at Catalent’s facility uncovers data, equipment & QC issues
24 Oct 2022 //
ENDPTS
Catalent’s Cook Pharmica slapped with a Form 483 by FDA
13 Sep 2018 //
FIERCE PHARMA
Roche recalls Valium in Australia after tampering uncovered
02 Jun 2017 //
FIERCE PHARMA
Approved new drug for rare disease
07 Nov 2016 //
ANVISA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.